Nucleix Ltd.

11 patents currently held · Updated Nov 14, 2026

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Aug 2030

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Jul 9, 2027
The maintenance fee for Kits and Methods for Diagnosing Lung Cancer (US 11,866,786) comes due Jul 9, 2027. Unpaid by Jan 10, 2028, it lapses early.
1 fee due Oct 9, 2027
The maintenance fee for Kits and Methods for Detecting Cancer-Related Mutations (US 11,952,632) comes due Oct 9, 2027. Unpaid by Apr 10, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Patent	Title	Status	Expires	Confidence
US 9,458,503	Methods for distinguishing between natural and artificial DNA samples In force Term ends Aug 8, 2030 · From the USPTO record	In force	Term ends Aug 8, 2030	From the USPTO record
US 9,783,850	Identification of source of DNA samples In force Term ends Sep 16, 2031 · From the USPTO record	In force	Term ends Sep 16, 2031	From the USPTO record
US 9,476,100	Methods for diagnosing bladder cancer In force Term ends Jul 6, 2035 · From the USPTO record	In force	Term ends Jul 6, 2035	From the USPTO record
US 11,525,134	Devices, systems and methods for ultra-low volume liquid biopsy In force Term ends Oct 26, 2038 · From the USPTO record	In force	Term ends Oct 26, 2038	From the USPTO record
US 11,866,786	Kits and Methods for Diagnosing Lung Cancer In force Term ends Jan 17, 2039 · High confidence	In force	Term ends Jan 17, 2039	High confidence
US 11,629,375	Methods and Kits for Determining the Efficiency of Plasma Separation from Whole Blood In force Term ends Feb 25, 2039 · High confidence	In force	Term ends Feb 25, 2039	High confidence
US 12,378,602	Methods and kits for determining the efficiency of plasma separation from whole blood In force Term ends Sep 22, 2039 · From the USPTO record	In force	Term ends Sep 22, 2039	From the USPTO record
US 11,434,528	Methods and Systems for Detecting Methylation Changes in DNA Samples In force Term ends Mar 17, 2040 · High confidence	In force	Term ends Mar 17, 2040	High confidence
US 12,152,273	Methods and Systems for Detecting Methylation Changes in DNA Samples In force Term ends Mar 17, 2040 · High confidence	In force	Term ends Mar 17, 2040	High confidence
US 12,462,935	Deep learning-based methods, devices, and systems for prenatal testing In force Term ends May 28, 2041 · From the USPTO record	In force	Term ends May 28, 2041	From the USPTO record

10 of 11 patents shown.

Pro members see all 11.

Pro members: see all 11 patents

Also on record, not counted in the 11: 1 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

9 pending · 1 abandoned · 2 no status recorded

List them